Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "therapy"
Too many choices? Use the filter option on the left to narrow your product listing.
Compare
TheraPRO® CHO Expansion Medium - 1L
Catalog #: BESP1630Q
Chemically defined, non-animal origin (NAO), serum-free medium
Compare
TheraPRO® CHO Feed - 5L
Catalog #: BESP1603BX
Chemically defined, non-animal origin (NAO), serum-free medium
Compare
TheraPRO® CHO Production Medium - 5L
Catalog #: BESP1571B
Chemically defined, non-animal origin (NAO), serum-free medium
Compare
TheraPRO® CHO Cloning Medium - 1L
Catalog #: BESP1609Q
Chemically defined, non-animal origin (NAO), serum-free medium
Added to Your Shopping Cart
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Digitalizing Cell & Gene Therapy ManufacturingCase study examining how MES Solutions improve operational efficiency and save costs.
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
Developing Patient-specific Cell Therapy Manufacturing ProcessesPoster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
-
Cell Therapy Services - Your Product. Our Passion.
-
Pluripotent Stem Cells: From Research to TherapyLonza Webinar Presentation
-
Integrated, Scalable Solutions for Cell and Gene Therapy -
the next path to cell and gene therapy success…Brochure showcasing Lonza products and servies from discovery to commercialization
-
Cell Therapies – From Early Technology Evaluations to Commercial ApprovalWatch the roundtable discussion for an update on current and future trends as well as challenges and solutions for the development of cellular immunotherapies. -
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
Product Availability by Store Location
Hours